CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Clinical trials sponsored by CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., explained in plain language.
Pharmaceutical manufacturer, subsidiary of CSPC Group.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New injection for high cholesterol begins first human safety tests Results expected Nov 2026 (estimated)
- New drug SYH2061 tested in healthy people for first time Results expected Nov 2026 (estimated)
- New schizophrenia shot could offer cheaper alternative to Brand-Name drug Results expected Dec 2026 (estimated)
- New injection aims to tackle stubborn high cholesterol and triglycerides Results expected Apr 2027 (estimated)
- New schizophrenia shot could offer cheaper alternative to abilify maintena Results expected Sep 2027 (estimated)
-
New shot takes aim at stubborn high cholesterol
Disease control CompletedThis study tested a new injection called SYH2053 in 156 adults with high cholesterol. The goal was to see if it lowers bad cholesterol (LDL-C) better than a placebo or an existing treatment. Participants followed a low-fat diet and either took their usual cholesterol meds or none…
Phase 2 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New schizophrenia drug injection shows promise in bioequivalence trial
Disease control CompletedThis study tested whether a new paliperidone palmitate injection works the same as the standard one in 256 Chinese patients with schizophrenia. Patients received either the new or the standard injection, and researchers measured drug levels in the blood to see if they matched. Th…
Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC